Zinc

Masayoshi Yamaguchi, Ph.D., IOM, FAOE, DDG, DG, is Adjunct Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA (2013 - ). Dr. Yamaguchi is engaged in the fields of endocrinology and cell signaling since 1971, and these researches are developed in the aspect of biochemistry, molecular biology, endocrinology, metabolism, nutrition, pharmacology, and toxicology. Dr Yamaguchi has an interesting for cell signaling mechanism, bone biology, nutritional factor and osteoporosis prevention, diabetes and diabetic osteoporosis, cancer biology, and cancer cell bone metastasis. Dr. Yamaguchi discovered two novel proteins and genes; cell signaling suppressor protein (named regucalcin; 1978) and transcriptional factor RGPR-p117 (regucalcin gene promoter region-related protein; 2001). Dr Yamaguchi generated regucalcin transgenic rats, which were registered as international patents including USA, EU and Japan, and this animal was found to induce osteoporosis and hyperlipidemia. Moreover, Dr. Yamaguchi proposed the potential role of regucalcin as a key suppressor protein in carcinogenesis. Thus far, Dr Yamaguchi published over 550 English articles to professional journals with peer-review, and registered over 20 national and international patents.

Preface; Inhibition Characteristic of Vegetable Extracts on the Corrosion of Al-Zn Alloys in Simulated Acidic Environment; ZnO-based Thick-film Electrodes for an Anode of Li-ion Batteries; Zinc in prostate cancer: the study based on synchrotron radiation techniques; Zinc & Atherosclerosis ; New Insights into the Role of Zinc in Cardioprotection during Ischemia/Reperfusion Injury; Use of Zinc Supplementation for Modulating the Immune Response; Zinc & Bone Homeostasis: Zinc Supplementation Prevents Osteoporosis; Index.